What can rheumatologists learn from translational cancer therapy?

Jonathan P Sherlock, Andrew D Filer, John D Isaacs, Christopher D Buckley

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
130 Downloads (Pure)


It is well established that an intimate connection exists between inflammation and neoplasia. Indeed, particular chronic infections and autoimmune processes giving rise to prolonged site-specific inflammation are known to increase the probability of the development of specific cancers. Molecular characterisation of these processes has revealed profound similarities in the specific molecules involved in persistence of inflammation and in both the primary induction of neoplastic processes and in specification of the preferred anatomic sites of metastatic spread. The therapeutic importance of these findings is underscored by the remarkable success in the treatment of autoimmune pathology using medications initially developed for use in oncology and this arena is one of considerable therapeutic promise for rheumatologists.

Original languageEnglish
JournalArthritis Research & Therapy
Issue number114
Publication statusPublished - 1 May 2013


  • Autoimmune Diseases
  • Humans
  • Inflammation
  • Neoplasms
  • Rheumatology
  • Translational Medical Research


Dive into the research topics of 'What can rheumatologists learn from translational cancer therapy?'. Together they form a unique fingerprint.

Cite this